Related Experiment Video

Updated: Apr 19, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.7K

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically

Rebecca M Hill1, Sanne Kuijper2, Janet C Lindsey1

  • 1Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE1 4LP, UK.

Cancer Cell
|December 24, 2014
PubMed

Insights

At medulloblastoma relapse, combined MYC amplification and P53 defects indicate aggressive disease. Targeting these P53-MYC interactions may offer new therapeutic strategies for aggressive pediatric brain tumors.

Area of Science:

  • Pediatric oncology
  • Cancer biology
  • Genetics

Background:

  • Medulloblastoma is the most common malignant pediatric brain tumor.
  • Tumor recurrence often presents with distinct biological features compared to initial diagnosis.
  • Understanding the molecular drivers of medulloblastoma relapse is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the molecular changes occurring in medulloblastoma at the time of relapse.
  • To explore the functional interaction between MYC family genes and the P53 pathway in medulloblastoma progression.
  • To identify potential therapeutic targets for relapsed medulloblastoma.

Main Methods:

  • Analysis of serial medulloblastoma biopsies from diagnosis and relapse.
  • Utilized a transgenic mouse model of MYCN-driven medulloblastoma.
  • Investigated the impact of p53 abrogation and restoration on tumor growth and characteristics.
  • Assessed the effects of MYCN suppression (genetic and therapeutic) on tumor progression.

Main Results:

  • Combined MYC family amplifications and P53 pathway defects frequently emerged at relapse in human patients.
  • Relapsed tumors with these combined defects were associated with rapidly progressive and fatal disease.
  • In a mouse model, abrogation of p53 function in MYCN-driven tumors led to aggressive, relapsed-like characteristics.
  • Restoring p53 activity or suppressing MYCN reduced tumor growth and improved survival in the model.

Conclusions:

  • P53-MYC interactions at medulloblastoma relapse serve as biomarkers for clinically aggressive disease.
  • These P53-MYC interactions represent a potential therapeutic vulnerability in relapsed medulloblastoma.
  • Targeting the interplay between P53 and MYC may offer novel treatment strategies for patients with recurrent pediatric brain tumors.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.3K
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.4K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.2K